Ampicillin Nanoparticles Production via Supercritical CO2 Gas Antisolvent Process
Journal Title: AAPS PharmSciTech - Year 2015, Vol 16, Issue 6
Abstract
The micronization of ampicillin via supercritical gas antisolvent (GAS) process was studied. The particle size distribution was significantly controlled with effective GAS variables such as initial solute concentration, temperature, pressure, and antisolvent addition rate. The effect of each variable in three levels was investigated. The precipitated particles were analyzed with scanning electron microscopy (SEM) and Zetasizer Nano ZS. The results indicated that decreasing the temperature and initial solute concentration while increasing the antisolvent rate and pressure led to a decrease in ampicillin particle size. The mean particle size of ampicillin was obtained in the range of 220–430 nm by varying the GAS effective variables. The purity of GAS-synthesized ampicillin nanoparticles was analyzed in contrast to unprocessed ampicillin by FTIR and HPLC. The results indicated that the structure of the ampicillin nanoparticles remained unchanged during the GAS process.
Authors and Affiliations
Nadia Esfandiari, Seyyed M. Ghoreishi
Keywords
Related Articles
- EP ID EP682285
- DOI 10.1208/s12249-014-0264-y
- Views 85
- Downloads 0
Evaluation of Tadalafil Nanosuspensions and Their PEG Solid Dispersion Matrices for Enhancing Its Dissolution Properties
The aim of this work was to prepare and evaluate Tadalafil nanosuspensions and their PEG 4000 solid dispersion matrices to enhance its dissolution rate. Nanosuspensions were prepared by precipitation/ultrasonication tech...
A Study on the Impact of Hydroxypropyl Methylcellulose on the Viscosity of PEG Melt Suspensions Using Surface Plots and Principal Component Analysis
An understanding of the rheological behaviour of polymer melt suspensions is crucial in pharmaceutical manufacturing, especially when processed by spray congealing or melt extruding. However, a detailed comparison of the...
Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism
In a previous study, generally lower drug release rates from RL:L55 blend coated pellets in neutral/basic release media than in acidic release media were reported. The aim of this study was to obtain information on the d...
Electrospinning of Cross-Linked Magnetic Chitosan Nanofibers for Protein Release
Iron(III) chloride hexahydrate (FeCl3.6H2O), (FeCl2·4H2O) was purchased from Merck Co. Medium molecular weight chitosan (CTS, 75 and 85% deacetylated), bovine serum albumin (BSA), and acetic acid (TFA, _98%) were...
Model Drug as Pore Former for Controlled Release of Water-Soluble Metoprolol Succinate from Ethylcellulose-Coated Pellets Without Lag Phase: Opportunities and Challenges
The objective of the present study was to evaluate the feasibility of using model drug metoprolol succinate (MS) as a pore former to modify the initial lag phase (i.e., a slow or non-release phase in the first 1–...